21 reports

  • Other prominent vendors

It has an annual pregnancy rate of less than ##%.

  • Contraceptive
  • World
  • Allergan plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Global laparotomy sponges market segmentation by geography
  • analysis

Also, the rise in gastrointestinal disorders has fueled the demand for abdominal surgeries.

  • Contraceptive
  • United States
  • World
  • Medtronic, Inc.
  • Owens & Minor, Inc.

Each patch lasts for one week.

  • Contraceptive
  • Market Size
  • Allergan plc
  • Bayer AG
  • Merck & Co., Inc.

The auto exports exceeded over ## million each year.

  • Diagnostic Reagent
  • China
  • Demand
  • Market Size
  • Biosino Bio-Technology & Science Inc

Copper IUDs are one of the most commonly used IUDs.

  • Contraceptive
  • Actavis plc
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceuticals Ltd.

Jia No. ##, Hualan Ave., Xinxiang, Henan, ## P. R.

  • Diagnostic Reagent
  • China
  • Beijing BGI-GBI Biotech Co., Ltd
  • Biosino Bio-Technology & Science Inc
  • Livzon Group

Jia No. ##, Hualan Ave., Xinxiang, Henan, ## P. R.

  • Diagnostic Reagent
  • China
  • Beijing BGI-GBI Biotech Co., Ltd
  • Biosino Bio-Technology & Science Inc
  • Livzon Group

OVARIES ARE THE MOST FREQUENTLY AFFECTED ORGANS AND THE GASTROINTESTINAL TRACT IS THE MOST COMMON EXTRAPELVIC SITE OF ENDOMETRIOSIS (APGO, 2016).

  • Contraceptive
  • Japan
  • United States
  • AbbVie Inc.
  • Takeda Pharmaceutical Company Limited
  • DRUG FOR FEMALE CONTRACEPTION - DRUG PROFILE
  • Drug for Female Contraception - Drug Profile

Similarly, the Universities' portfolio in Pre-Registration, Phase II and Preclinical stages comprises ##, ## and ## molecules, respectively.

  • Contraceptive
  • United States
  • World
  • Product Initiative
  • Mithra
  • Drug for Female Contraception - Drug Profile

Similarly, the Universities' portfolio in Phase III, Phase II and Preclinical stages comprises ##, ## and ## molecules, respectively.

  • Contraceptive
  • Hormone
  • United States
  • Product Initiative
  • Mithra

GASTROINTESTINAL, WOMEN' S HEALTH & DIVERSIFIED BRANDS LINZESS®NET REVENUES IN THE FIRST QUARTER OF 2018 WERE $##. ## MILLION, AN INCREASE OF ##. ## PERCENT VERSUS THE PRIOR YEAR QUARTER.

  • Contraceptive
  • United States
  • Company
  • Company Financials
  • Allergan plc

The company' s product portfolio encompasses medicines to treat gynaecological diseases, cardiovascular diseases, gastrointestinal diseases and central nervous system disorders.

  • Contraceptive
  • Canada
  • Europe
  • United States
  • Mithra

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Contraceptive
  • Genitourinary System Disease
  • Therapy
  • World
  • Product Initiative

(NYSE: GI), which offers physicians a broad portfolio of products to treat gastrointestinal conditions, for approximately $## million.

  • Contraceptive
  • Drug Discovery And Development
  • United States
  • Company
  • GlobalData's company
  • Women's Health, Global, Overall Pharmaceutical Industry Pipeline by Therapy Area, 2018

In Vivo; ##(##): ##-## Malin EK, et al. (2015). Gastrointestinal symptoms among endometriosis patients-A case-cohort study.

  • Contraceptive
  • Genitourinary System Disease
  • OTC
  • World
  • Deals & Alliance

The prominent features of this report are - ##.

  • Clinical Trial
  • Contraceptive
  • Genitourinary System Disease
  • World
  • Bayer AG

Merck KG ## ## ## ## ## ## Merck & Co Inc ## ## ## ## ## ## LO. LI.

  • Clinical Trial
  • Contraceptive
  • Endocrine Disease
  • Hormone
  • World

Merck KG ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## Ferring Holding SA ## ## ## ## ## ## Eugonia IBSA Institut Biochimique SA ## ## ## ## ## ## ## ## ## ## ## ## LO. LI.

  • Clinical Trial
  • Contraceptive
  • Hormone
  • Pharmaceutical
  • World

Over the same period, Women' s Health revenues and Gastrointestinal revenues were $##. ## million and $##. ## million, respectively.

  • Clinical Trial
  • Contraceptive
  • Therapy
  • United States
  • GlobalData's company

The prominent features of this report are - ##.

  • Clinical Trial
  • Contraceptive
  • Hormone
  • Pharmaceutical
  • World

The prominent features of this report are - ##.

  • Clinical Trial
  • Contraceptive
  • Hormone
  • World
  • Merck & Co., Inc.